Patricia Stefancin1, Christine Cahaney1, Robert Parker2, Thomas Preston1, Jessica Goldstein1, Rina Meyer2, Cara Giannillo1, Debra Giugliano1, Tim Duong1, and Laura Hogan2
1Stony Brook Medicine, Stony Brook, NY, United States, 2Stony Brook Children's Hospital, Stony Brook, NY, United States
Synopsis
The concept of pediatric chemobrain and the neural mechanisms that
underlie its development have not been adequately studied. In this study, MRI
was used to examine the neuroanatomy of childhood cancer survivors. We found
reduced brain volumes and cortical thicknesses in childhood cancer survivors
compared to age-matched controls. These changes were in regions known to be
involved in working-memory function and executive function, which could account
for the development of executive function difficulties observed in childhood
cancer survivors. These findings may prove useful to inform treatment
strategies and modify behavioral programs to help survivors combat these
issues.
Introduction
Improved cancer treatments have resulted in longer survival of childhood
cancer patients 1, 2. However, many
survivors show difficulties in working memory, attention, cognitive switching,
and visuospatial distortion, which have been attributed to chemotherapies used3-5 (ca. chemobrain). Although
chemobrain has been well studied in breast cancer survivors, it has not been
adequately studied in pediatric cancer patients. This study tested the
hypothesis that chemotherapy-treated pediatric cancer survivors show reduced regional
brain volumes and cortical thickness when compared to age-matched controls. Methods
Fifteen
chemotherapy-treated childhood cancer survivors diagnosed with a non-central
nervous system cancer before the age of 18 and seventeen healthy age-matched
controls were studied. Exclusions included prior cranial radiation therapy, known
neuropsychiatric disorders, or contraindications for MRI.
To
evaluate for memory, attention and fine motor skills, subjects underwent the
NEPSY-II, Purdue Pegboard and N-back working-memory tasks (0-back and 2-back
paradigm). Parents also completed the Behavioral Rating Inventory of Executive
Functioning (BRIEF) Parental Rating.
Subjects completed a
3D-MPRAGE MRI at 3T (TR=2300ms, TE=3.24ms, FOV=223x223 mm, thk=0.87mm, and
0.9x0.9x0.9mm). Structural volumes were normalized to MNI space, and segmented
using tissue probability maps. Voxel-based morphometry (VBM) and cortical
thickness analysis were performed using CAT12 toolbox for SPM. Subcortical
volumetric analysis was performed using FSL FIRST. Statistical and correlation
analysis were performed using SPSS. Results
Compared
to controls, patients showed smaller total-brain volume (T=-2.1, p=0.043), gray-matter
(T=-2.2, p=0.03), and white-matter (T=-2.1, p=0.046) volumes. VBM analysis showed
smaller gray-matter volume in patients in the right orbitofrontal area (T=-5.1,
p=0.001), right anterior prefrontal cortex (T=-4.8, p=0.001), and right
supramarginal gyrus (T=-4.5, p=0.030) compared to controls. Cortical thickness
analysis showed thinning of the right temporal pole (T=-6.2, p=0.002) and
thickening of the right parahippocampal gyrus in the patient group. Patients
revealed reduced volume in the right thalamus (T=-4.01, p=0.001), left thalamus
(T=-4.6, p<0.001), and left nucleus accumbens (T=-3.2, p=0.004).
On
the working-memory task, patients had fewer correct responses and more incorrect
and no-responses than controls. They also had longer response times on all
trials compared to controls. The number of correct answers positively
correlated with total brain volume (R2=0.459, p=0.018) and
white-matter volume (R2=0.453, p=0.023) while the number of
incorrect negatively correlated with total brain volume (R2=-0.424,
p=0.031) and white-matter volume (R2=0.424, p=0.031). The number of
no-response trials negatively correlated with the right thalamus volume (R2=-0.366,
p=0.006) and the left nucleus accumbens volume (R2=-0.730,
p<0.001).
Patients showed deficits
by NEPSY-II and Purdue Pegboard scores but none by BRIEF total score or
sub-scores compared to normative data. However, these results did not significantly
correlate with differences in regional brain volumes or cortical thicknesses. Discussion
The
anterior prefrontal cortex and supramarginal gyrus are involved in working
memory function, albeit distinct components, as demonstrated by individuals
with damage to these areas 7,8,9. The orbitofrontal area is
associated with higher order reasoning and decision making8 while the thalamus is one of the major relay stations
in the brain. These areas are involved in working memory, decision-making, and
the relaying and processing of information. It is conceivable that they play
some role in poorer working memory performance given the correlations observed
between decreased global brain and white matter volumes with inferior
performance on the working memory task.
The
right temporal pole also showed reduced cortical thickness which may be significant
given that it is involved in memory retrieval, something known to be deficient in
childhood cancer survivors 10. Alternatively, the cortical thickening of the right parahippocampal
gyrus, which is known to be involved in memory encoding and retrieval, was
increased in patients. Although it may seem contradictory, this cortical
thickening may be associated with increased effort in memory and coordination
tasks reported by chemobrain patients.
There are only a
handful of other studies on volumetric changes in pediatric cancer survivors. Neurocognitive scores measuring
working memory and inhibition were correlated with the volumes of the amygdala,
11. No papers
documented changes in cortical thickness.Conclusion
Chemotherapy in pediatric cancer survivors likely caused changes in regional
brain volumes and cortical thickness consistent with problems that survivors
face with working memory and cognitive function. Acknowledgements
No acknowledgement found.References
. Kaiser J, Bledowski C, Dietrich J.
Neural correlates of chemotherapy-related cognitive impairment. Cortex.
2014;54:33-50.
2. Campbell LK, Scaduto M, Sharp W, et al.
A meta-analysis of the neurocognitive sequelae of treatment for childhood acute
lymphocytic leukemia. Pediatr Blood Cancer. 2007;49(1):65-73.
3. Anderson FS, Kunin-Batson AS.
Neurocognitive late effects of chemotherapy in children: the past 10 years of
research on brain structure and function. Pediatr Blood Cancer.
2009;52(2):159-164.
4. Robinson KE, Livesay KL, Campbell LK,
et al. Working memory in survivors of childhood acute lymphocytic leukemia:
functional neuroimaging analyses. Pediatr Blood Cancer. 2010;54(4):585-590.
5. Jacola LM, Krull KR, Pui CH, et al.
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood
Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. J
Clin Oncol. 2016;34(11):1239-1247.
6. Jim HS, Phillips KM, Chait S, et al.
Meta-analysis of cognitive functioning in breast cancer survivors previously
treated with standard-dose chemotherapy. J Clin Oncol. 2012;30(29):3578-3587.
7. Ramnani N, Owen AM. Anterior prefrontal
cortex: insights into function from anatomy and neuroimaging. Nat Rev Neurosci.
2004;5(3):184-194.
8. Rudebeck PH, Rich EL. Orbitofrontal
cortex. Curr Biol. 2018;28(18):R1083-R1088.
9. Russ MO, Mack W, Grama CR, et al.
Enactment effect in memory: evidence concerning the function of the
supramarginal gyrus. Exp Brain Res. 2003;149(4):497-504.
10. Chadwick MJ, Anjum RS, Kumaran D, et al.
Semantic representations in the temporal pole predict false memories. Proc Natl
Acad Sci U S A. 2016;113(36):10180-10185.
11. Aminoff EM, Kveraga K, Bar M. The role of
the parahippocampal cortex in cognition. Trends Cogn Sci. 2013;17(8):379-390.